San Diego, CA -- (SBWIRE) -- 05/23/2016 -- An investor in shares of IMS Health Holdings Inc filed a lawsuit in effort to halt the proposed takeover of Danbury, CT based IMS Health Holdings Inc by Quintiles Transnational Holdings.

Investors who purchased shares of IMS Health Holdings Inc (NYSE:IMS) and currently hold any of those NYSE:IMS shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The plaintiff alleges that the defendants breached their fiduciary duties owed to NYSE:IMS stockholders by agreeing to sell IMS Health Holdings Inc too cheaply via an unfair process to Quintiles Transnational Holdings.

On May3, 2016, IMS Health Holdings Inc and Quintiles Transnational Holdings Inc.announced that their respective boards of directors approved a merger agreement, pursuant to which the companies will be combined in an all-stock merger of equals transaction. Under the terms of the merger agreement, IMS Health Holdings Inc (NYSE:IMS) shareholders will receive a fixed exchange ratio of 0.384 shares of Quintiles common stock for each share of IMS Health common stock. Based on a closing price of $69.10 per NYSE:Q shares on May 2, 2016, shareholders of IMS Health Holdings Inc (NYSE:IMS) will receive a value of approximately $26.53 per NYSE:IMS share.

However, plaintiff claims that the proposed consideration NYSE:IMS shareholders will receive is grossly inadequate and undervalues IMS Health Holdings. Indeed, at least one analyst has set the high target price for NYSE:IMS shares at $32.00 per share. Furthermore, IMS Health Holdings Inc reported that its annual Total Revenue rose from over $2.64 billion in 2014 to over $2.92 billion in 2015 and that its Net loss of $189 million in 2014 turned into a Net Income of $417 million in 2015. Shares of IMS Health Holdings Inc (NYSE:IMS) reached as high as 33.15 per share in July 2015. In addition, the plaintiff alleges that the process is also unfair to NYSE:IMS stockholders. The plaintiff says that the defendants agreed to preclusive deal protection devices, such as a $250 million termination fee, no-solicitation, and matching rights provision, that deter other bidders from making a superior offer for IMH Health Holdings.

On May 19, 2016, NYSE:IMS shares closed at $24.65 per share.

Those who are current investors in IMS Health Holdings Inc shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com